# FDA Inspection 1176074 - David Lynch, M.D. - July 22, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/david-lynch-md/160e00ad-79bc-48e7-885c-ff44df1a4ca6
Source feed: FDA_Inspections

> FDA Inspection 1176074 for David Lynch, M.D. on July 22, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1176074
- Company Name: David Lynch, M.D.
- Inspection Date: 2022-07-22
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1271270 - 2025-05-13](https://www.globalkeysolutions.net/records/fda_inspections/david-lynch-md/fd4decb8-40f2-4ec6-a2c9-b5da46471b39)
- [FDA Inspection 1271270 - 2025-05-13](https://www.globalkeysolutions.net/records/fda_inspections/david-lynch-md/88b94abf-4ca6-4407-9ba9-f452a2211b4e)

Company: https://www.globalkeysolutions.net/companies/david-lynch-md/19cf14c1-dffe-492e-9f69-271fae993aa4

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c